This is likely a secondary effect of the increased glucose level in the tubular fluid due to SGLT2‐inhibition‐induced glucosuria and an unknown interplay between GLUT9 or the urate transporter URAT1 [31]. Here, SLC22A12 is linked to Glycosuria.